Evaluating anti-sickling therapies for sickle cell disease: a microfluidic assay for red blood cell-mediated microvascular occlusion under hypoxia is a research paper published in Lab on a Chip (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Small Business Innovation Research
Grant: R41HL172662
Small Business Innovation Research
Grant: R42DK119048
Small Business Innovation Research
Grant: R44HL140739
Fogarty International Center
Grant: D43TW012260
National Institutes of Health
Grant: 5R42DK119048-03
Portable, affordable, quantitative microchip electrophoresis for hemoglobin A1C testing
National Institutes of Health
Grant: 2R44HL140739-04
Affordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias
National Institutes of Health
Grant: 5D43TW012260-03
Strengthening Research Capacity in Innovative Global Health Technologies for Non-Communicable Diseases in Uganda
National Institutes of Health
Grant: 1R41HL172662-01
RHODA: Rapid Hemoglobin-Oxygen Dissociation Assay
Keywords